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Previous studies suggest that thymus produces a ho-
mogenous population of natural regulatory T (Treg)
cells that express a transcriptional factor FOXP3
and control autoimmunity through a cell-contact-
dependent mechanism. We found two subsets of
FOXP3+ natural Treg cells defined by the expression
of the costimulatorymolecule ICOS in the human thy-
mus and periphery. Whereas the ICOS+FOXP3+ Treg
cells used interleukin-10 to suppress dendritic cell
function and transforming growth factor (TGF)-b to
suppress T cell function, the ICOSFOXP3+ Treg
cells used TGF-b only. The survival and proliferation
of the two subsets of Treg cells were differentially
regulated by signaling through ICOS or CD28, re-
spectively. We suggest that the selection of natural
Treg cells in thymus is coupled with Treg cell differ-
entiation into two subsets imprinted with different
cytokine expression potentials and use both cell-
contact-dependent and independent mechanisms
for immunosuppression in periphery.
INTRODUCTION
CD4+CD25+, naturally occurring regulatory T (Treg) cells consti-
tute 5%–10% of peripheral CD4+ T cells, which play an essential
role in the active suppression of autoimmunity in both humans
and rodents. Treg cells appear to differentiate as a unique T
cell lineage from the developing T cells in the thymus at either
the CD4+CD8+ double positive (DP) thymocyte or CD4+CD8
single positive (SP) thymocyte stage. It has become increasingly
clear that the intrathymic development of Treg cells depends on
signaling through T cell receptor (TCR) with medium to high affin-
ity for self-antigens, interleukin-2 (IL-2), and signaling through the
costimulatory receptor CD28. FOXP3, a member of the forkhead
transcriptional-factor family, has been demonstrated to be the
critical regulator of Treg cell development in the thymus, as
well as Treg cell suppressive function (Fontenot et al., 2003;
Hori et al., 2003; Khattri et al., 2003). However, the molecular
mechanism by which the FOXP3+ Treg cell mediates immuno-
suppression has remained elusive. Although in vivo experiments870 Immunity 28, 870–880, June 2008 ª2008 Elsevier Inc.suggest that IL-10 and transforming growth factor (TGF)-b may
be involved in the Treg cell-mediated immunosuppresion (Asse-
man et al., 1999; Belkaid et al., 2002; Fahlen et al., 2005; Green
et al., 2003; Nakamura et al., 2001), in vitro data are conflicting on
the involvement of IL-10 in Treg cell-mediated immunosuppre-
sion (Jonuleit et al., 2001; Piccirillo et al., 2002; Taams et al.,
2001; Thornton and Shevach, 1998). Currently, three major types
of CD4+ Treg cells have been proposed: the CD4+FOXP3 IL-10-
producing Treg cells or Tr1 cells that are generated during
immune responses in the periphery (Vieira et al., 2004), The TGF-
b-expressing T helper type 3 (Th3) cells are originally identified
in mice after oral-tolerance induction to myelin basic protein
(MBP) (Chen et al., 1994; Weiner, 2001), and naturally occurring
FOXP3+ Treg cells generated in the thymus (Annunziato et al.,
2002; Stephens et al., 2001). In this study, we report the identifi-
cation of two subsets of naturally occurring FOXP3+ Treg cells
generated in thymus according to their differential expression
of a costimulatory receptor ICOS. Whereas the ICOS+FOXP3+
Treg cells used IL-10 to suppress dendritic cell (DC) function
and TGF-b to suppress T cell function, the ICOSFOXP3+ Treg
cells used TGF-b mainly. The survival and proliferation of the
two subsets of Treg cells were regulated by signaling through
ICOS or CD28, respectively. Our study suggest that the mole-
cules used by the ICOS+FOXP3+ and ICOSFOXP3+ naturally
occurring Treg cells to mediate immunosuppression mirror those
used by the peripheral Tr1 cells and Th3 cells, respectively. The
selection of FOXP3+ Treg cells in the thymus is probably coupled
to their differentiation into the ICOS+FOXP3+ phenotype, which
is imprinted with the high IL-10-producing capacity, and the
ICOSFOXP3+ subset is imprinted with the high TGF-b-expres-
sion capacity.
RESULTS
Identification of ICOS+ and ICOSFOXP3+ Treg
Cells in Human Thymus
During a study on the expression of costimulatory molecules in
the human thymus, we found that FOXP3+ Treg cells within the
thymic medulla (Figure 1A) were grouped into two subsets,
ICOS+ and ICOS (Figure 1B). Because signaling through ICOS
primes CD4+ T cells to produce IL-10 (Akbari et al., 2002; Hutloff
et al., 1999; Lohning et al., 2003, Ito et al., 2007; Janke et al.,
2006), we questioned whether the ICOS+ and ICOS Treg cells
were functionally different. The CD25+ICOS+ and CD25+ICOS
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Defined by ICOS Expression in Thymus
(A) Double staining of FOXP3 (red) and ICOS (blue)
in the human thymus showing the FOXP3+ICOS+
and FOXP3+ICOS Treg cell subsets located
in the thymic medulla at a low magnification
(1003). The scale bar represents 50 mm.
(B) Double immunofluorescence staining of
FOXP3 (red) and ICOS (green) performed on the
same section of thymus further confirmed the
two FOXP3+ T cell populations: nuclear FOXP3+
cytoplasmic ICOS+ T cells and nuclear FOXP3+
cytoplasmic ICOS T cells.
(C) Flow-cytometric analysis of ICOS and CD25
expression on CD4+CD8 thymocytes and FOXP3
expression in sorted two Treg cell subsets.
(D) Flow-cytometric analysis of intracellular cyto-
kines (IL-10 and IL-2) in each thymic Treg cell sub-
set after two rounds of culturing with anti-CD3 in
the presence of IL-2 and IL-7 on parental L cells
or ICOSL-L cells for 5 days. Numbers in the quad-
rant represent percentage of cells.
(E) Flow-cytometric analysis of membrane TGF-
b on each thymic Treg cell subset after culturing
with anti-CD3 in the presence of IL-2 and IL-7 on
parental L cells or ICOSL-L cells for 5 days. Num-
bers in the histograms indicate the mean fluores-
cence intensity, which is calculated by subtraction
of mean fluorescence intensity with the isotype
control from that with the anti-TGF-b antibody.
(F) Proliferative response of CD4+CD25 T cells
and thymic CD25hiICOS+ CD4+ Treg cells or
CD25hiICOS CD4+ Treg cells primed with anti-
CD3 in the presence of IL-2 and IL-7 on ICOSL-L
cells for 5 days and their mixtures in response to
T cell-depleted peripheral blood mononuclear
cells was assessed by [3H]thymidine incorporation. Ratio of Treg cells to CD4+CD25 T cells is 1 to 2. Error bars represent the SEM of triplicate wells. Similar
results were observed in four (A and B) and three (C–F) independent experiments, and the results of a representative experiment are shown.Immunity 28, 870–880, June 2008 ª2008 Elsevier Inc. 871subsets were isolated from the CD4+CD8 thymocytes and both
were found to express FOXP3 (Figure 1C). The ICOS+FOXP3+
Treg cells acquired the ability to produce more IL-10 (9%–20%
by intracellular IL-10 staining) than the ICOSFOXP3+ Treg cells
did (3%–6%) after priming with anti-CD3 or anti-CD3 plus
ICOS-ligand (ICOSL) (Figure 1D). By contrast, the ICOSFOXP3+
Treg cells expressed greater amounts of membrane-bound
TGF-b1 (mTGF-b) than the ICOS+FOXP3+ Treg cells (Figure 1E).
Both subsets were anergic and had the ability to suppress
CD4+CD25 T cell proliferation in responses to allogeneic stimu-
lation (Figure 1F). These data suggest that the human thymus may
generate two functionally distinct FOXP3+ Treg cell subsets.
ICOS+FOXP3+ and ICOSFOXP3+ Treg Cells
in Peripheral Lymphoid Tissues and Blood
We determined whether ICOS+FOXP3+ and ICOSFOXP3+ Treg
cells generated in the thymus exist in the periphery, and we
found that human tonsils and lymph nodes indeed contained
ICOS+FOXP3+ and ICOSFOXP3+ Treg cells in the T cell-rich
and subepithelial cell areas (Figures 2A–2D). The germinal center
(GC) contained large numbers of ICOS+ follicular T helper cells,
with small numbers expressing FOXP3 (Figures 2A and 2B).
The CD25+ICOS+FOXP3+ and CD25+ICOSFOXP3+ Treg cell
subsets were also found in the blood (Figure 2E). Quantitative
analysis from six human thymuses and 18 human peripheralblood samples showed that the percentage of the ICOS+FOXP3+
Treg cells was 4.02% in thymus versus 2.45% in the peripheral
blood and the percentage of the ICOSFOXP3+ Treg cells was
2.56% in the thymus versus 3.59% in the periphery (Figure 2F).
Although both Treg cell subsets expressed similar amounts
of CD28, CD27, CD58, CD54, CD62L, and CCR7, the
ICOS+FOXP3+ cell subset expressed relatively greater amounts
of CTLA-4 and CD38 (Figure 3A). Both subsets expressed little
or no CD127 (IL-7Ra [Liu et al., 2006; Seddiki et al., 2006a]),
CRTH2 (a marker for Th2 memory cells [Wang et al., 2006]),
CD57 (a marker for follicular T helper cells in humans [Rasheed
et al., 2006]), and CD103.
Recent studies have shown that there are at least two popula-
tions of FOXP3+ Treg cells in human adult blood, one with
CD45RA+ naive phenotype and one with CD45RO+ memory phe-
notype (Seddiki et al., 2006b; Valmori et al., 2005). The FOXP3+
Treg cells with the CD45RA+ naive phenotype represent the ma-
jority in human cord blood (Takahata et al., 2004). To establish the
relationship of the two subsets of FOXP3+ Treg cells classified by
ICOS expression and the two subsets of FOXP3+ Treg cells
based on the expression of CD45 isoforms, we analyzed the
expression of CD45RA and CD45RO by the ICOS+FOXP3+ and
ICOSFOXP3+ Treg cells from both adult blood (Figure 3A) and
cord blood (Figure 3B). Although all the ICOS+FOXP3+ Treg cells
expressed CD45RO, the ICOSFOXP3+ Treg cells contained
Immunity
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ure 3A). In contrast, although the majority of the cord blood
CD25+FOXP3+ Treg cells had high CD45RA expression, the
ICOS+FOXP3+ Treg cells contained a fraction of Treg cells with
the CD45RO+CD45RAlow memory phenotype (Figure 3B). These
data suggest that the ICOS+FOXP3+ Treg cells from both adult
and cord blood are more related to the Treg cells with the memory
phenotype and the ICOSFOXP3+ Treg cells are more related
to the Treg cells with the naive phenotype previously reported.
In addition, the CD25+FOXP3+ Treg cells did not express the
typical naive T cell phenotype.
Another recent study has divided the peripheral FOXP3+ Treg
cells into a MHC class II+ subset and a MHC class II subset
(Baecher-Allan et al., 2006). However, the ICOS+FOXP3+ and
ICOSFOXP3+ Treg cells did not show substantial differences
in MHC class II expression (data not shown). Finally, in order
to establish the relationship between the two subsets of Treg
cells in the blood with the FOXP3+CD31+ recent thymic emi-
grant (Valmori et al., 2005, Haas et al., 2007, Kimmig et al.,
2002), we analyzed the expression of CD31 by flow cytometry
Figure 2. TwoSubsets of FOXP3+ TregCells
Defined by ICOS Expression in Periphery
(A and B) Double staining of FOXP3 (red) and
ICOS (blue) in the (A) human tonsil and (B) lymph
node showing two FOXP3+ T cell populations:
FOXP3+ICOS+ T cells and FOXP3+ICOS T cells
at a low magnification (1003). All scale bars
represent 50 mm.
(C and D) Immunofluorescence staining of FOXP3
(red) and ICOS (green) performed on the same
section of (C) tonsil and (D) lymph node showing
two FOXP3+ T cell populations: nuclear FOXP3+
cytoplasmic ICOS+ Treg cells and nuclear
FOXP3+ cytoplasmic ICOS Treg cells.
(E) Human peripheral blood CD25hiCD4+ Treg cells
were separated into ICOS+ and ICOS subpopula-
tions. Intranuclear FOXP3 expression in each
subset was determined by flow cytometry.
(F) Percentages of two subsets of Treg cells in six
thymus and 18 adult blood from healthy donors.
Percentages of CD25hiICOS+CD4+ Treg cells and
CD25hiICOSCD4+ Treg cells among whole
CD4+ T cells were determined by flow cytometry.
Bars represent the group means. Statistical
significance was determined with paired Stu-
dent’s t test. Similar results were observed in three
(A–D) and five (E) independent experiments, and
the results of a representative experiment are
shown.
(Figures 3A and 3B). We found that
50% of the ICOS+FOXP3+ Treg cells
and all of the ICOSFOXP3+ Treg cells
in cord blood expressed CD31, therefore
suggesting that both subsets of Treg
cells contain the recent thymic emi-
grants. Interestingly, fewer cells from
both subsets of Treg cells in adult blood
expressed CD31, consistent with the
fact that there is a dramatic decrease in the thymic output
during adult life.
The ICOS+FOXP3+ Treg Cells Have the Ability
to Produce the High Amounts of IL-10
We investigated whether the two subsets of Treg cells had a sim-
ilar capacity to produce cytokines. First, we examined the IL-10
and IL-2 production by the total Treg cells and separately as two
Treg cell subsets, as well as naive and memory T cells immedi-
ately after activation for 6 hr with phorbol myristate acetate
plus ionomycin (with FACS analyses) or for 24 hr with anti-CD3
plus anti-CD28 (with enzyme-linked immunosorbent assay
[ELISA]). We found that the CD25+FOXP3+ICOS+ Treg cells con-
tained the greatest numbers of IL-10-producing cells, which is
approximately four times more than the CD25+FOXP3+ICOS
subset (Figure 4A). Although freshly isolated naive and memory
T cells produced high amounts of IL-2, the two subsets of Treg
cells produced very low amounts of IL-2 immediately after acti-
vation, as analyzed by both flow cytometry (Figure 4A) and IL-2
ELISA (Figure 4C), as expected of Treg cells. We found that872 Immunity 28, 870–880, June 2008 ª2008 Elsevier Inc.
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amounts of IL-4, IL-5, IL-13, IFN-g, TNF-a, and mTGF-b without
priming (data now shown).
We then examined the capacity of cytokine production by the
two Treg cell subsets after 5 days of priming with anti-CD3 or
anti-CD3 plus ICOSL. Although 5-day-primed total Treg cells
and the two subsets of Treg cells produced more IL-2 than the
freshly isolated Treg cell subsets did, they produced much less
IL-2 than the 5-day-primed naive and memory CD4+ T cells as
indicated by both FACS (Figure 4B) and ELISA analyses (Fig-
ure 4D). In contrast, we found that the ICOS+ Treg cells produced
large amounts of IL-10 (47%–76% by intracellular IL-10 staining
(Figure 4B and Figure S1B available online), and 4.9–7.9 ng/ml by
IL-10 ELISA [Figure S1C]). However, the ICOS Treg cells
produced only a moderate amounts of IL-10 (8%–16% by intra-
cellular IL-10 staining [Figure 4B and Figure S1B] and 0.8–1.4 ng/ml
by IL-10 ELISA [Figure S1C]). In addition, the ICOS+ Treg cells
produced more IFN-g but less TNF-a and IL-2 than the ICOS
Treg cells did (Figures S1A–S1C). Both subsets of Treg cells
produced low or undetectable amounts of IL-4 or IL-13 (Fig-
ures S1A and S1C). After 5 days of activation by anti-CD3,
although the ICOS+FOXP3+ Treg cells maintained their high ex-
pression of CD25, ICOS, CTLA4, and FOXP3, the ICOSFOXP3+
Treg cells acquired the expression of ICOS and CTLA4 and
maintained the expression of CD25 and FOXP3 (Figures S1D).
However, the ICOSFOXP3+ Treg cells did not acquire the
capacity to produce high IL-10 (Figure 4B, and Figures S1B and
S1C). Two color flow-cytometric analyses further showed that
although ICOSFOXP3+ Treg cells and CD25CD45RO+ mem-
ory T cells rapidly expressed ICOS after activation and division
(Figure S1E), they produced much lower amounts of IL-10
Figure 3. Phenotype of Two FOXP3+ Treg
Cell Subsets in Adult and Cord Blood
(A and B) Phenotypical analysis of two subsets of
Treg cells in (A) adult blood and (B) cord blood. In-
tranuclear FOXP3 and intracytoplasmic CTLA4
and the cell-surface markers on sorted blood
CD25hiICOS+CD4+ and CD25hiICOSCD4+ Treg
cells were determined by flow cytometry. Similar
results were observed at least in three indepen-
dent experiments for each marker, and the results
of a representative experiment are shown.
than did the in vivo-derived ICOS+ Treg
cells (Figure S1F). These data suggest
that the two subsets of FOXP3+ Treg
cells did not interconvert after in vitro
activation.
Because the ICOS+FOXP3+ Treg cells
had the capacity to secrete more IL-10
than the ICOSFOXP3+ Treg cells after
priming, we questioned whether the
ICOS+FOXP3+ Treg cells have the capac-
ity to produce more IL-10 than other CD4+
T cell subsets. Peripheral blood CD4+ T
cells were separated by cell sorting into
CD45RO naive T cells, CD45RO+ICOS+
memory T cells, and CD45RO+ICOS
memory T cells (Figure 5A). After 5 days of priming with anti-
CD3 or anti-CD3 plus ICOSL, the major IL-10-producing cells
were found to be in the CD45RO+ICOS+ memory T cells
(Figure 5A). We then analyzed the capacity of IL-10 production
among all CD45RO+ memory T cell subsets including:
CD25FOXP3 nonregulatory T cells, CRTH2+ Th2 memory
cells, CD25ICOS+ follicular Th-like cells (Rasheed et al., 2006),
ICOS+ Treg cells, and ICOS Treg cells (Figure 5B). After 5
days of culture, the ICOS+ Treg cells were found to produce the
highest amounts of IL-10 (Figures 5C and 5D). All other subsets
produced 10%–20% the amounts of IL-10 (Figures 5C and 5D).
These data suggest that the CD25+FOXP3+ICOS+ Treg cells
have the ability to produce the greatest amounts of IL-10 among
the circulating CD4+ T cell pool.
The ICOSFOXP3+ Treg Cells Express Greater
Amounts of TGF-b than Other CD4+ T Cells
Because TGF-b has been suggested to be the major molecule
used by the FOXP3+ Treg cells for immunosuppression (Fahlen
et al., 2005; Green et al., 2003; Nakamura et al., 2001), we
analyzed the expression of mTGF-b by the ICOS+FOXP3+
Treg cells, the ICOSFOXP3+ Treg cells, and the CD4+
CD25FOXP3 T cells after activation. We found that the ICOS
Treg cells expressed higher amounts of mTGF-b than the ICOS+
Treg cells did and the CD25CD45RO+ total memory T cells did
not express mTGF-b (Figure 4E). These findings, which were
confirmed by quantitative polymerase chain reaction analyses
(Figure 4F), suggest that the CD4+CD25+FOXP3+ naturally
occurring Treg cells can be divided into an ICOS+ subset that
has the capacity to produce massive amounts of IL-10 and
express moderate amounts of mTGF-b and an ICOS subsetImmunity 28, 870–880, June 2008 ª2008 Elsevier Inc. 873
Immunity
Two Treg Cell Subsets in Human Thymus and Peripherythat expresses higher amounts of mTGF-b but produce low
amounts of IL-10.
ICOS+FOXP3+ and ICOSFOXP3+ Treg Cells Use
Different Molecular Mechanisms for Suppression
An important question is whether the ICOS+ and ICOSTreg cells
have different functions. CD4+CD45ROCD25 naive T cells un-
derwent strong proliferation in culture with allogeneic myeloid
DCs, which was strongly inhibited by activated ICOS+ Treg cells
and ICOSTreg cells (Figure 6A). Neutralizing antibody to IL-10 or
TGF-b inhibitor partially blocked the inhibitory function of ICOS+
Treg cells, and anti-IL-10 plus TGF-b inhibitor led to a complete
block, as indicated by [3H]thymidine incorporation (Figure 6B)
and CFSE-labeling experiments (Figure 6C). However, only
TGF-b inhibitor but not anti-IL-10 blocked the function of ICOS
Treg cells (Figures 6B and 6C). The ICOS Treg cell-mediated
suppression through mTGF-b was dependent on the cell-cell
contact because a Transwell system completely block the func-
tion of ICOS Treg cells, whereas ICOS+ Treg cell-mediated sup-
pression was only partially blocked by the Transwell (Figure 6D).
This is consistent with the fact that the ICOS+ Treg cells used both
mTGF-b and soluble IL-10 suppression mechanisms. We found
Figure 4. Different Capacity of Two Treg
Cell Subsets to Produce Cytokines
Blood CD25hiICOS+ Treg cells, CD25hiICOS Treg
cells, and whole CD25hiCD4+ Treg cells, as well as
CD25CD45RO naive and CD25CD45RO+
memory T cells were isolated by the same donor.
(A)–(D) show analysis of IL-10 and IL-2 production
by (A and C) freshly isolated T cell subsets or
(B and D) T cells primed for 5 days with anti-CD3
in the presence of IL-2 on parental L cells by intra-
cellular cytokine staining (A and B) and ELISA (C
and D). Numbers in the quadrant represent per-
centage of cells. ELISA data are means ± SEM of
four independent experiments. (E) shows flow-
cytometric analysis of membrane TGF-b on the
primed blood Treg cell subsets after culturing
with anti-CD3 in the presence of IL-2 on parental
L cells or ICOSL-L cells for 5 days. The numbers
in the histograms indicate the mean fluorescence
intensity, which is calculated by subtraction of
mean fluorescence intensity with the isotype
control from that with the anti-TGF-b antibody.
(F) shows the real-time quantitative RT-PCR
analysis for TGF-b mRNA expression in blood
CD25CD45RO+CD4+ memory T cells and two
Treg cell subsets after culturing with anti-CD3
in the presence of IL-2 for 5 days. Data are
means ± SEM of three independent experiments.
Similar flow-cytometric results were observed in
three independent experiments (A, B, and E), and
the results of a representative experiment are
shown.
that CD86 expression on DCs was sup-
pressed by the coculture with ICOS+
Treg cells but not by the ICOS Treg cells,
and this suppression was restored by
anti-IL-10 (Figure 6E), indicating that
ICOS+ Treg cells use IL-10 to inhibit DC
maturation. Freshly isolated ICOS+ and ICOS Treg cells
show similar functions when compared with the primed ICOS+
and ICOS Treg cells in the above experimental systems
(Figure S2).
Survival and Proliferation of ICOS+FOXP3+
and ICOSFOXP3+ Treg Cells
Are Differentially Regulated
Another key question is whether the survival and expansion of
the peripheral ICOS+ Treg cells and ICOS Treg cells were differ-
entially regulated. We found that the ICOS+ Treg cells but not
ICOS Treg cells underwent massive apoptosis in culture with-
out IL-2, unless signaling through ICOS (Figures 7A and 7B). In
the presence of IL-2, ICOSL strongly promoted the proliferation
of anti-CD3-activated ICOS+ Treg cells (Figure 7C). By contrast,
anti-CD28 strongly inhibited the proliferation of ICOS+ Treg cells
induced by anti-CD3 plus ICOSL. However, both ICOSL and
anti-CD28 promoted the proliferation of ICOS Treg cells and
CD4+ naive T cells induced by anti-CD3 and IL-2 (Figure 7C).
These suggest that the survival and homeostatic proliferation
of the ICOS+ Treg cells and ICOS Treg cells are regulated by
different costimulatory molecules.874 Immunity 28, 870–880, June 2008 ª2008 Elsevier Inc.
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(A) Blood CD4+ T cells were separated into ICOS+CD45RO+ memory, ICOSCD45RO+ memory, and ICOSCD45RO naive T cells on the basis of the expression
of ICOS and CD45RO. Flow-cytometric analysis of intracellular cytokines in each T cell subset after culturing with anti-CD3 in the presence of IL-2 on parental L
cells or ICOSL-L cells for 5 days.
(B) Flow-cytometric analysis of FOXP3 expression by five subsets of CD4+CD45RO+ memory subpopulations: CD25ICOSCD45RO+ memory, CD25ICOS+
follicular Th-like, CD25+ICOS+ Treg, CD25+ICOS Treg, and CD25lowCD45RO+CRTH2+ Th2 memory T cells.
(C and D) Five blood CD4+ memory T cell subpopulations were cultured with anti-CD3 in the presence of IL-2 on parental L cells or ICOSL-L cells for 5 days. IL-10
production by T cell subsets were analyzed by (C) flow cytometry and (D) ELISA. ELISA data are means ± SEM of four independent experiments. Similar flow-
cytometric results were observed in four independent experiments (A–C), and the results of a representative experiment are shown. Numbers in the dot plots
represent percentage of cells.Plasmacytoid DCs but Not Myeloid DCs Promote
the Proliferation of ICOS+ Treg Cells through ICOSL
We and other have recently shown that although plasmacytoid
DCs (pDCs) preferentially express ICOSL, myeloid DCs (mDCs)
preferentially express CD80 and CD86 after activation (Ito
et al., 2007; Janke et al., 2006). pDCs but not mDCs have unique
ability to prime naive CD4+ T cells to differentiate into IL-10-pro-
ducing cells (Kadowaki and Liu, 2002; Rissoan et al., 1999).
Therefore, we further investigated whether the pDCs and mDCs
may differentially regulate the proliferation of the ICOS+ Treg
cells versus the ICOS Treg cells. We found that pDCs but not
mDCs selectively promoted the proliferation of the autologous
ICOS+ Treg cells (Figure 7D). The ability of pDCs to promote
the proliferation of the ICOS+ Treg cells was dependent on
ICOSL but not on CD80 and CD86 (Figure 7D). By contrast,
mDC preferentially promoted the proliferation of the autologous
ICOS Treg cells through CD80-and-CD86-dependent mecha-
nism (Figure 7D). These data suggest that although the homeo-
stasis of the ICOS+ Treg cells is preferentially maintained by
the pDCs through ICOSL, homeostasis of the ICOS Treg cells
is preferentially maintained by the mDCs through CD80 and
CD86.DISCUSSION
In this study, we reported the identification of two subsets of
natural FOXP3+ Treg cells in human thymus, peripheral blood,
and secondary lymphoid tissues. The ICOS+ Treg cell subset
used two mechanisms for immunosuppression, namely IL-10-
mediated suppression of antigen-presenting cell function and
mTGF-b-mediated T cell-T cell-contact-dependent suppres-
sion. In contrast, the ICOS Treg cell subset used predominantly
the mTGF-b-mediated T cell-T cell contact-dependent suppres-
sion. The ICOS+ Treg cells displayed a striking propensity to
undergo rapid apoptosis in culture, unless signaled by ICOSL.
In addition, ICOS and CD28 costimulation had opposing effects
on the ICOS+ Treg cells; although ICOSL costimulated their pro-
liferation, anti-CD28 signaling inhibited their proliferation. By
contrast, the ICOS Treg cells did not display such propensity
for apoptosis and anti-CD28 signaling strongly promoted their
proliferation. We provided additional experimental data showing
that although activated pDCs preferentially promoted the prolif-
eration of the autologous ICOS+ Treg cells through ICOSL, acti-
vated mDCs preferentially promoted the proliferation of the
autologous ICOS Treg cells through B7 signaling.Immunity 28, 870–880, June 2008 ª2008 Elsevier Inc. 875
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Two Treg Cell Subsets in Human Thymus and PeripheryFigure 6. Suppressive Function of Two Subsets of Treg Cells
CD4+ naive T cells and autologous CD25hiICOS+CD4+ Treg cells or CD25hiICOS-CD4+ Treg cells were sorted from human peripheral blood. CD4+ naive T cells
were used as responder, and primed Treg cells after culturing with anti-CD3 in the presence of IL-2 on ICOSL-L cells for 5 days were used as suppressor. Mixtures
of T cell populations were cultured for 5 days with allogeneic monocyte-derived DCs as stimulator. The results with primed Treg cells as suppressor were shown
here, and those with freshly isolated Treg cells were shown in Figure S2. In (A), ratios of Treg cells to naive T cells are shown. Proliferation was assessed by [3H]thy-
midine incorporation, and error bars represent the SEM of triplicate wells. As shown in (B), neutralizing IL-10 plus IL-10 receptor antibodies and/or TGF-b receptor
type I (TbRI) inhibitor were added into T cell culture. The ratio of Treg cells to naive T cells is 1 to 2. Proliferation was assessed by [3H]thymidine incorporation, and
error bars represent the SEM of triplicate wells. Statistical significance was determined with Student’s t test. **p < 0.01. As shown in (C), CD4+ naive T cells were
labeled with CFSE before culture, and cells after culturing were analyzed by flow cytometry, gated on CD4+CFSE+ cells. The ratio of Treg cells to naive T cells is 1
to 2. As shown in (D), indicated T cell populations were cultured in Transwell at 1:2 ratio of Treg cells to naive T cells with allogeneic monocyte-derived DCs.
Proliferation was assessed by [3H]thymidine incorporation, and error bars represent the SEM of triplicate wells. As shown in (E), primed Treg cells, naive T cells,
and allogeneic monocyte-derived DCs were cultured at 1:1:1 ratio. After 4 days of culture, CD86 expression on DCs was analyzed by flow cytometry, gated on
CD11c+ cells. The filled histogram indicates CD86 expression on DCs in coculture with naive T alone, and the line histogram indicates CD86 expression on DCs in
coculture with naive T and Treg cells. The dot histogram indicates isotype control on DCs. Similar results were observed in three independent experiments (A–E),
and the results of a representative experiment are shown.An important question is whether the ICOS+ Treg cells are re-
ally generated in the thymus or whether ICOS+ Treg cells are sim-
ply derived from the ICOS Treg cells in the periphery after acti-
vation. Although it is possible that the ICOS Treg cells can be
converted into the ICOS+ Treg cells in the periphery under similar
circumstances that induce the generation of IL-10-producing Tr1
cells from naive T cells, the following lines of evidence support
the concept that thymus not only plays a critical role in the selec-876 Immunity 28, 870–880, June 2008 ª2008 Elsevier Inc.tion of the FOXP3+ naturally occurring Treg cells but also has
the ability to imprint the two Treg cell subsets that have the
potential to produce different cytokines in the periphery upon
activation. First, both newborn thymus and cord blood already
contains the ICOS+FOXP3+ Treg cells, and furthermore, thymus
appears to contain more ICOS+FOXP3+ Treg cells than the adult
peripheral blood. Second, although ICOS is rapidly upregulated
on ICOS nonregulatory T cells and ICOSFOXP3+ Treg cells,
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do not acquire the ability to produce high amounts of IL-10 as the
in vivo-derived ICOS+ Treg cells. Third, the dramatic differences
between the ICOS+FOXP3+ Treg cells and ICOSFOXP3+ Treg
cells in terms of susceptibility to apoptosis and differential
molecular regulation of survival and proliferation suggest that
the two subsets have undergone very different differentiation
programs in the thymus and that one does not simply represent
the other one at a transient activation state. Fourth, we found that
all the ICOSFOXP3+ Treg cells and50% of the ICOS+FOXP3+
Treg cells from cord blood expressed CD31, a marker for the re-
cent thymic emigrants (Valmori et al., 2005, Haas et al., 2007,
Kimmig et al., 2002), suggesting that the two subsets could be
derived directly from the thymus. Interestingly, although 30%
of ICOSFOXP3+ Treg cells expressed CD31, only a small per-
centage of the ICOS+FOXP3+ Treg cells expressed CD31 in adult
blood; this may be because adult thymus has a selective reduc-
tion in its ability to produce the ICOS+FOXP3+ Treg cells, which
can be caused by either a reduced ability for positive selection or
an increased deletion of this subset of Treg cells.
Similar to GITR, CTLA4, and CD25, ICOS is a T cell activation
maker, and they all can be upregulated on naive T cells upon
activation. Although CD25 can be readily rapidly induced on
peripheral nonregulatory T cells upon activation by anti-CD3
stimulation, however, these in vitro-activated CD25+ T cells do
not become regulatory T cells. We believe that the expression
of ICOS during FOXP3+ Treg cell selection reflects dramatic func-
tional changes on the FOXP3+ Treg cells in terms of cytokine pro-
Figure 7. Survival and Expansion of Two
Treg Cell Subsets Were Differentially
Regulated
(A and B) Sorted blood CD25hiICOS+CD4+ Treg
cells and CD25hiICOSCD4+ Treg cells were cul-
tured in the absence of IL-2 on the indicated con-
ditions for 5 days. (A) shows flow-cytometric anal-
ysis of annexin V staining on each Treg cell subset
after culturing. The numbers in the histograms in-
dicate the percentage of cells in the gate. In (B),
the number of viable T cells counted by trypan-
blue exclusion is shown in the bar graph.
(C) A total of 5 3 104 Treg cell subsets or CD4+
naive T cells were cultured in the presence of IL-2
on the indicated conditions for 5 days. The viable
cell number of each T cell subset counted by
trypan-blue exclusion is shown. Bars represent
means of four experiments.
(D) A total of 5 3 104 Treg cell subsets were cul-
tured with autologous blood pDCs or mDCs (DC/
T cell ratio of 1:2) for 4 days in the presence of
IL-2 and neutralizing ICOSL mAb or neutralizing
CD80 plus CD86 mAbs. The viable cell number of
each Treg cell subset counted by trypan-blue
exclusion is shown. Similar results were observed
in three (A) and four (B and D) independent
experiments, and the results of a representative
experiment are shown.
duction potential (such as IL-10 and TGF-
b expression) and molecular regulation of
cell survival and proliferation. Our study
highlights an important principle in the de-
velopmental immunology that a signal upregulating ICOS or
CD25 on T cells during their development in thymus has more
dramatic impact on their function than a similar event that affects
the mature T cells in the periphery. In another word, early educa-
tion in thymus is more important.
Currently, three types of Treg cells have been reported, includ-
ing FOXP3+ naturally occurring Treg cells, inflammation-induced
IL-10-producing Tr1 cells, and TGF-b-expressing Th3 cells
(O’Garra and Vieira, 2004; Roncarolo and Levings, 2000; Thomp-
son and Powrie, 2004). IL-10-producing Tr1 cells were originally
isolated from patients who have severe combined immunodefi-
ciency and who had undergone successful HLA-mismatched
bone marrow transplantation (Bacchetta et al., 1994; Groux
et al., 1997). Subsequently, IL-10-producing Tr1 cells were gen-
erated from naive CD4+ T cells during antigen-driven T cell im-
mune responses (Asseman and Powrie, 1998; McGuirk et al.,
2002). It was recently shown that IL-10-producing Tr1 cells gen-
erated in vitro from naive CD4+ T cells in the presence of dexa-
methasone and the active form of vitamin D3 did not express
FOXP3 (Vieira et al., 2004). Our finding that the FOXP3+ICOS+
naturally occurring Treg cells produced the greatest amounts
of IL-10 after activation among all CD4+ T cell subsets suggests
that FOXP3+ICOS+ naturally occurring Treg cells are the major
precursors of circulating IL-10-producing regulatory T cells and
may play a complementary function with the IL-10-producing
Tr1 cells that are generated during inflammation in the tissues.
The TGF-b-expressing Th3 cells were originally identified in
mice after oral-tolerance induction to MBP (Chen et al., 1994;Immunity 28, 870–880, June 2008 ª2008 Elsevier Inc. 877
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Th1 effector cells in a TGF-b-dependent fashion in vivo and
in vitro (Chen et al., 1994). The identification of the FOXP3+ICOS
Treg cell subset that mainly uses mTGF-b but not IL-10 to directly
inhibit T cell proliferation suggests that the CD25+FOXP3+ICOS
Treg cells may represent major precursors of circulating TGF-b-
expressing regulatory T cells and may play a complementary
function with the TGF-b-expressing Th3 cells that are generated
during inflammation in the tissues. Therefore, the two subsets
of naturally occurring FOXP3+ Treg cells may functionally mirror
the two subsets of peripheral-induced Treg cells.
In vivo studies demonstrated that the function of FOXP3+ Treg
cells depends on IL-10 and/or TGF-b (Asseman et al., 1999;
Belkaid et al., 2002; Fahlen et al., 2005; Green et al., 2003; Naka-
mura et al., 2001). However studies using cultured and cloned
CD4+CD25+ Treg cells in vitro have generated conflicting data
as to whether the Treg cell function depends on IL-10 or
TGF-b (Jonuleit et al., 2001; Piccirillo et al., 2002; Taams et al.,
2001; Thornton and Shevach, 1998). Recent studies showed
that the cultured or cloned human CD4+CD25+ Treg cells
expressed TGF-b but not IL-10 and these cells depend on
TGF-b for immune regulation and were distinct from the IL-10-
producing Tr1 cells (Annunziato et al., 2000; Levings et al.,
2002). Our current study suggests that these studies may have
overlooked the function of the ICOS+FOXP3+ Treg cell subset.
This is because that the ICOS+FOXP3+ Treg cell subset that
has the ability to produce a huge amount of IL-10 is more prone
to undergoing apoptosis in cultures than the ICOSFOXP3+ Treg
cell subset is. In addition, IL-10 does not directly inhibit T cell
proliferation induced by anti-CD3 and anti-CD28; it only inhibits
T cell proliferation by blocking the function of antigen-presenting
cells, such as DCs. However, many studies on Treg cell function
use a T cell proliferation assay induced by anti-CD3 and anti-
CD28. Recent studies show the presence of FOXP3+IL-10+
Treg cells preferentially colonize the lamina propria of colon
(Kamanaka et al., 2006; Uhlig et al., 2006). Our study suggests
that the ICOS+FOXP3+ and ICOSFOXP3+ Treg cells may have
preferences in homing to different tissues.
Currently, both thymic epithelial cells and DCs have been sug-
gested to select Treg cells in thymus (Aschenbrenner et al., 2007;
Bensinger et al., 2001; Goldschneider and Cone, 2003; Liu,
2006; Watanabe et al., 2005). In the periphery, DCs were shown
to play key roles in the induction and maintenance of FOXP3+
Treg cells (Kretschmer et al., 2005; Tarbell et al., 2006). Subsets
of intestinal DC or macrophage subsets were recently shown to
selectively induce the generation of FOXP3+ Treg cells through
retinoid acids (Coombes et al., 2007; Sun et al., 2007). These to-
gether with our current findings that the pDCs and mDCs play
a different role in regulating the proliferation of the ICOS+FOXP3+
Treg cells and ICOSFOXP3+ Treg cells, respectively, suggest
that the ICOS+FOXP3+ and the ICOSFOXP3+ Treg cells are
selected and educated by different population of antigen-pre-
senting cells within the thymus.
EXPERIMENTAL PROCEDURES
Isolation of Treg Cell Subsets
The institutional review board for human research at the M.D. Anderson Cancer
Center approved this study. Human thymuses from fetuses (1923 weeks of878 Immunity 28, 870–880, June 2008 ª2008 Elsevier Inc.gestation), newborns, and children (2 days to 2 years old) were obtained from
Advanced Bioscience Resources and the Texas Children’s Hospital, respec-
tively. Cord bloods were obtained from M.D. Anderson Cancer Center (Depart-
ment of Bone Marrow Transplantation). Adult blood buffy coats from healthy
donors were obtained from the Gulf Coast Regional Blood Center, Texas.
The following antibodies were used for cell sorting on a FACSAria (BD Biosci-
ences) to reach >99% purity: phycoerythrin (PE)-Cy5.5- or allophycocyanin
(APC)-Cy7-conjugated anti-CD4 (S3.5), APC-conjugated anti-CD8 (SK1), fluo-
rescein isothiocyanate (FITC)-, PE-, or PE-Cy7-conjugated anti-CD25 (M-
A251), and biotinylated ICOS (ISA-3) antibodies and then PE- or APC-strepta-
vidin. For the isolation of T cell lineage thymocytes, thymuses were digested
and mononuclear cells were separated by Ficoll centrifugation. CD4+T cell lin-
eage thymocytes were obtained by negative depletion with a mixture of mouse
monoclonal antibodies against markers CD8, CD11c, CD14, CD15, CD20,
CD56, and CD235a. This was followed by incubation with goat anti-mouse
IgG-coated magnetic beads (M-450, Dynal). CD4+CD8CD25+ICOS+ and
CD4+CD8CD25+ICOS thymocytes were isolated by cell sorting. For the iso-
lation of cord blood and adult blood CD4+ Treg cell subsets, CD4+CD25+ T cells
were enriched by a CD4+CD25+ regulatory T cell Isolation Kit (Miltenyi Biotec).
CD4+CD25hiICOS+ and CD4+CD25hiICOS Treg cell subsets were isolated by
cell sorting. For detection of intranuclear FOXP3, an anti-FOXP3 (PCH101;
eBioscience) staining kit was used. For detection of membrane-bound TGF-
b1 on the surface, cells were stained with TGF-b1 (27232; R&D Systems) anti-
body (Nakamura et al., 2001); this was followed by staining with PE- or APC-
conjugated mouse IgG1 antibodies (BD Biosciences). The labeling of T cells
with CFSE (Molecular Probes) was performed, as described (Watanabe et al.,
2005). Isolation of the naive, memory, or other T cell subsets and the other
antibodies used are described in the Supplemental Data online.
T Cell Culture
Sorted blood T cell subsets were cultured for 5 days on irradiated CD32-ex-
pressing parental L cells or CD32/ICOSL-expressing L cells (ICOSL-L cells)
(described in the Supplemental Experimental Procedures) precoated with
CD3 antibody (OKT3; 0.2 mg/ml) in the presence of 50 U/ml of IL-2 (eBio-
science) in 48-well culture plates (T cell-to-L cell ratio 2.5:1). In some experi-
ments, soluble CD28 antibody (28.2; 1 mg/ml) or isotype-matched control
was added in the culture. In another experiment, autologous 5 3 104 Treg
cell subsets were cultured with blood pDCs or mDCs (DC/T cell ratio of 1:2)
in round-bottomed 96-well culture plates for 4 days in the presence of
50 mg/ml anti-ICOSL mAb (eBioscience) and a combination of 5 mg/ml anti-
CD80 and 10 mg/ml anti-CD86 mAbs (R&D Systems). pDCs and mDCs were
isolated from the buffy coat of healthy adult volunteers as previously described
(Ito et al., 2007; Watanabe et al., 2005). Sorted CD4+CD8CD25+ICOS+ and
CD4+CD8CD25+ICOS thymocytes were cultured for two rounds of 5 day
stimulation on parental L cells or ICOSL-L cells precoated with CD3 antibody
(0.2 mg/ml) in the presence of 50 U/ml of IL-2 and 20 ng/ml of IL-7 (R&D Sys-
tems). RPMI 1640 supplemented with 10% FCS, 2 mM L-glutamine, 1 mM so-
dium pyruvate, penicillin G, and streptomycin was used for cell cultures. The
generation of transfected L cells is described in the Supplemental Data online.
Analysis of Intracellular T Cell Cytokine Production
For detection of intracellular cytokine production, the T cells were restimulated
with 50 ng/ml of phorbol myristate acetate plus 2 mg/ml of ionomycin for 6 hr. A
total of 10 mg/ml brefeldin A was added during the last 2 hr. The cells were
stained with PE-anti-FOXP3 (PCH101), PE-anti-IL-4 (8D4-8), or PE-anti-TNF-a
(MAb11), PE- or FITC-anti-IL-2 (MQ1-17H12) or FITC-anti-IFN-g (B27), and
APC-anti-IL-10 (JES3-19F1) antibodies with the FOXP3 staining kit (eBio-
science) or Caltag FIX and PERM kit.
T Cell Cytokine Production by ELISA
The blood T cell subsets were collected, washed, and restimulated with plate-
bound 5 mg/ml CD3 and 2 mg/ml soluble CD28 antibodies at a concentration of
106 cells/ml for 24 hr. The levels of IL-2, IL-4, IL-10, IL-13, TNF-a, and IFN-g in
the supernatants were measured by ELISA (R&D Systems). Detail of real time
PCR methods is described in the Supplemental Experimental Procedures
online.
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We sorted 4 3 104 CD4+CD45ROCD25 naive T cells as responders
and different numbers of autologous CD4+CD25+ICOS+ Treg cells or
CD4+CD25+ICOS Treg cells as suppressors and stimulated these cell types
and their mixtures (at Treg-to-naive T cell ratio 1:2 or at different ratios) in
round-bottom 96-well plates for 5 days by culturing them with irradiated 2 3
104 allogeneic monocyte-derived DCs as stimulators that were generated
from isolated CD14+ monocytes by CD14-microbeads (Miltenyi Biotec) by
5 days of culturing with 200 ng/ml GM-CSF and 100 ng/ml IL-4 (R&D
Systems). In some experiments, we sorted 4 3 104 CD4+CD25 blood T cells
as responders and 2 3 104 thymic CD4+CD8CD25+ICOS+ Treg or
CD4+CD8CD25+ICOS Treg cells after culturing with CD3 antibody in the
presence of IL-2 and IL-7 on ICOSL-L cells for 5 days as suppressors, and these
cell type and their mixtures were examined in response to irradiated 4 3 104
anti-CD3 MACS-microbeads-T cell-depleted peripheral blood mononuclear
cells as stimulators. Mixture of neutralizing IL-10 antibody (200 ng/ml) plus
IL-10 receptor antibody (10 ng/ml) (R&D Systems) and/or TGF-b receptor
type I kinase (ALK5) inhibitor II (1 mM) (Calbiochem) were used in the cultures.
Cellular proliferation was assessed by [3H]thymidine incorporation, as de-
scribed (Wang et al., 2006; Watanabe et al., 2005), and was analyzed by flow
cytometry (CFSE). Transwell experiments were performed in 24-well plates
(Corning Costar), as described (Vieira et al., 2004). In brief, 43 105 naive T cells
were stimulated with 2 3 105 monocyte-derived DCs for 5 days, and 2 3 105
Treg cells were added into the same well or separated by semipermeable mem-
brane. In another experiment, naive T cells, autologous CD25+ICOS+ Treg or
CD25+ICOS Treg cells, and allogeneic immature DCs (1:1:1 ratio) were
cultured for 4 days, and then the cells were stained with PE-anti-CD11c,
FITC-anti-CD86, or FITC-mouse IgG1 antibodies (BD Biosciences) and
analyzed by flow cytometry.
T Cell Proliferation and Viability Assay
After 5 days of culture under the several conditions, we collected and resus-
pended Treg cells in an EDTA-containing medium to dissociate the clusters.
Viable cells were counted by Trypan-blue exclusion of the dead cells or by
annexin V staining (BD Biosciences).
Immunohistochemistry
Human lymph nodes were obtained from tissue bank of M.D. Anderson Cancer
Center with policies established by the institutional committees for human
research. Human tonsils were obtained from West Virginia Hospital. Immuno-
histological and immunoflurescence staining was performed with human ICOS
(ANC6C6-A3) and FOXP3 (PCH101) antibodies, as described (Wang et al.,
2006; Watanabe et al., 2005).
SUPPLEMENTAL DATA
Additional Experimental Procedures and two figures are available at http://
www.immunity.com/cgi/content/full/28/6/870/DC1/.
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